Julie Lang
Experienced in Breast Infection

Dr. Julie Lang

Surgical Oncology
Cleveland Clinic
Hillcrest Hospital
6780 Mayfield Road, 
Mayfield Hts, OH 
On Staff At
Clinical Trials:Currently Recruiting for 3 Trials
31 Years of Experience
Experienced in Breast Infection
Cleveland Clinic
Hillcrest Hospital
6780 Mayfield Road, 
Mayfield Hts, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Julie Lang is a Surgical Oncologist in Mayfield Hts, Ohio. Dr. Lang has been practicing medicine for over 31 years and is rated as an Experienced provider by MediFind in the treatment of Breast Infection. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Intraductal Papilloma, Tissue Biopsy, and Lymphadenectomy.

Her clinical research consists of co-authoring 90 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of North Carolina, 1995.0
Residency
UCSF Department of Surgery
Specialties
Surgical Oncology
Licenses
Surgery in CA
Board Certifications
American Board Of Surgery, 2006
Fellowships
MD Anderson Cancer Center
Hospital Affiliations
Cleveland Clinic
Hillcrest Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Provider Partners Health Plan
  • MEDICARE SNP
SummaCare
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Hillcrest Hospital
6780 Mayfield Road, Mayfield Hts, OH 44124
Call: 440-312-4500

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Core Biopsies of Breast Tumor Tissue Repository
Core Biopsies of Breast Tumor Tissue Repository
Enrollment Status: Recruiting
Publish Date: November 13, 2025
Intervention Type: Other
I-SPY Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)
I-SPY Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)
Enrollment Status: Recruiting
Publish Date: August 06, 2025
Intervention Type: Drug
Study Drugs: Standard Therapy, AMG 386 +/- Trastuzumab, AMG 479 (Ganitumab)+Metformin, MK-2206 +/- Trastuzumab, AMG 386+Trastuzumab, T-DM1+Pertuzumab, Pertuzumab+Trastuzumab, Ganetespib, ABT-888, Neratinib, PLX3397, Pembrolizumab - 4 Cycle, Talazoparib+Irinotecan, Patritumab+Trastuzumab, Pembrolizumab - 8 Cycle, SGN-LIV1A, Durvalumab+Olaparib, SD-101+Pembrolizumab, Tucatinib+Trastuzumab and Pertuzumab, Cemiplimab, Cemiplimab+REGN3767, Trilaciclib +/- Trastuzumab+Pertuzumab, SYD985 ([vic-]Trastuzumab Duocarmazine), Oral Paclitaxel+Encequidar+Dostarlimab (TSR-042)+Carboplatin +/- Trastuzumab, Oral Paclitaxel+Encequidar+Dostarlimab (TSR-042) +/- Trastuzumab
Study Phase: Phase 2
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
Enrollment Status: Recruiting
Publish Date: March 19, 2024
Intervention Type: Drug, Biological
Study Drugs: Remdesivir, Cenicriviroc, Icatibant, Pulmozyme, IC14, Celecoxib, Narsoplimab
Study Phase: Phase 2
Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal Women
Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal Women
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Other, Drug
Study Drug: Metformin Hydrochloride
Study Phase: Phase 3
Combined Breast MRI/Biomarker Strategies to Identify Aggressive Biology
Combined Breast MRI/Biomarker Strategies to Identify Aggressive Biology
Enrollment Status: Active_not_recruiting
Publish Date: April 11, 2025
Intervention Type: Procedure, Other
Study Phase: Not Applicable
A Large-scale Multicenter Phase II Study Evaluating the Protective Effect of a Tissue Selective Estrogen Complex (TSEC) in Women With Newly Diagnosed Ductal Carcinoma in Situ
A Large-scale Multicenter Phase II Study Evaluating the Protective Effect of a Tissue Selective Estrogen Complex (TSEC) in Women With Newly Diagnosed Ductal Carcinoma in Situ
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Other, Procedure, Drug
Study Drug: Conjugated Estrogens/Bazedoxifene
Study Phase: Phase 2
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
ISPY-P1.01: Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer: A Phase I/Ib Trial
ISPY-P1.01: Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer: A Phase I/Ib Trial
Enrollment Status: Withdrawn
Publish Date: November 18, 2023
Intervention Type: Drug
Study Phase: Phase 1
Harvest of Circulating Tumor Cells (CTCs) From Patients With Metastatic Breast Cancer (MBC) Using the Parsortix™ PC1 System
Harvest of Circulating Tumor Cells (CTCs) From Patients With Metastatic Breast Cancer (MBC) Using the Parsortix™ PC1 System
Enrollment Status: Completed
Publish Date: June 05, 2023
Intervention Type: Diagnostic test
Phase 1/2 Dose-Rising, Safety, Tolerability and Efficacy Study of Topical SOR007 for Cutaneous Metastases
Phase 1/2 Dose-Rising, Safety, Tolerability and Efficacy Study of Topical SOR007 for Cutaneous Metastases
Enrollment Status: Completed
Publish Date: November 05, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 7 Less Clinical Trials

89 Total Publications

Novel investigational modalities for clinical breast imaging: A narrative review.
Novel investigational modalities for clinical breast imaging: A narrative review.
Journal: Clinical imaging
Published: April 08, 2025
View All 89 Publications
Similar Doctors
Mary Murray
Distinguished in Breast Infection
Dr. Mary Murray
Surgical Oncology
Distinguished in Breast Infection
Dr. Mary Murray
Surgical Oncology

Akron General

1 Akron General Avenue, 
Akron, OH 
 (30.9 miles away)
330-344-6000
Languages Spoken:
English
See accepted insurances

Mary Murray is a Surgical Oncologist in Akron, Ohio. Dr. Murray is rated as a Distinguished provider by MediFind in the treatment of Breast Infection. Her top areas of expertise are Breast Infection, Fibrocystic Breast Disease, Intraductal Papilloma, Breast Cancer, and Lymphadenectomy.

Advanced in Breast Infection
Dr. Robert R. Shenk
Surgical Oncology | General Surgery
Advanced in Breast Infection
Dr. Robert R. Shenk
Surgical Oncology | General Surgery
11100 Euclid Ave, 
Cleveland, OH 
 (8.9 miles away)
216-844-7874
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Shenk is a Surgical Oncologist and a General Surgeon in Cleveland, Ohio. Dr. Shenk is rated as a Distinguished provider by MediFind in the treatment of Breast Infection. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Shenk is currently accepting new patients.

Amanda Mendiola
Advanced in Breast Infection
Dr. Amanda Mendiola
Surgical Oncology
Advanced in Breast Infection
Dr. Amanda Mendiola
Surgical Oncology

Akron General

1 Akron General Avenue, 
Akron, OH 
 (30.9 miles away)
330-344-6000
Languages Spoken:
English
See accepted insurances

Amanda Mendiola is a Surgical Oncologist in Akron, Ohio. Dr. Mendiola is rated as an Advanced provider by MediFind in the treatment of Breast Infection. Her top areas of expertise are Breast Cancer, Breast Lump, Intraductal Papilloma, Giant Mammary Hamartoma, and Lymphadenectomy.

VIEW MORE BREAST INFECTION DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lang's expertise for a condition
ConditionClose
  • Elite
  • Breast Cancer
    Dr. Lang is
    Elite
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Distinguished
  • HER-2 Positive Breast Cancer
    Dr. Lang is
    Distinguished
    . Learn about HER-2 Positive Breast Cancer.
    See more HER-2 Positive Breast Cancer experts
  • Inflammatory Breast Cancer
    Dr. Lang is
    Distinguished
    . Learn about Inflammatory Breast Cancer.
    See more Inflammatory Breast Cancer experts
  • Intraductal Papilloma
    Dr. Lang is
    Distinguished
    . Learn about Intraductal Papilloma.
    See more Intraductal Papilloma experts
  • Advanced
  • Angiosarcoma
    Dr. Lang is
    Advanced
    . Learn about Angiosarcoma.
    See more Angiosarcoma experts
  • Fibroadenoma
    Dr. Lang is
    Advanced
    . Learn about Fibroadenoma.
    See more Fibroadenoma experts
  • Giant Mammary Hamartoma
    Dr. Lang is
    Advanced
    . Learn about Giant Mammary Hamartoma.
    See more Giant Mammary Hamartoma experts
  • Paget Disease of the Breast
    Dr. Lang is
    Advanced
    . Learn about Paget Disease of the Breast.
    See more Paget Disease of the Breast experts
  • Subareolar Abscess
    Dr. Lang is
    Advanced
    . Learn about Subareolar Abscess.
    See more Subareolar Abscess experts
  • Triple-Negative Breast Cancer
    Dr. Lang is
    Advanced
    . Learn about Triple-Negative Breast Cancer.
    See more Triple-Negative Breast Cancer experts
  • Experienced
  • Adult Soft Tissue Sarcoma
    Dr. Lang is
    Experienced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • BRCA Positive Breast Cancer
    Dr. Lang is
    Experienced
    . Learn about BRCA Positive Breast Cancer.
    See more BRCA Positive Breast Cancer experts
  • Breast Infection
    Dr. Lang is
    Experienced
    . Learn about Breast Infection.
    See more Breast Infection experts
  • Breast Lump
    Dr. Lang is
    Experienced
    . Learn about Breast Lump.
    See more Breast Lump experts
  • Fibrocystic Breast Disease
    Dr. Lang is
    Experienced
    . Learn about Fibrocystic Breast Disease.
    See more Fibrocystic Breast Disease experts
  • Galactocoele
    Dr. Lang is
    Experienced
    . Learn about Galactocoele.
    See more Galactocoele experts
View All 11 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.